Chemicals and pharmaceuticals · ATNF

180 Life Sciences Corp.

12 filings mentioning 9 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
9topics disclosed
Chemicals and pharmaceuticalsindustry
NYbased in

Across 12 filings we hold, 180 Life Sciences Corp. has written down 9 of the topics we track. That places it 150 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

TopicFilingsMost recent
Internal Control152026-04-08
Restatement72025-12-10
Business Continuity62025-05-08
Enforcement Action62025-12-10
Artificial Intelligence32026-03-13
Regulatory Investigation12024-10-03
Ransomware12025-03-31
Material Weakness12025-08-11
Data Breach12026-03-27

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24
25
26

Recent filings

FiledFormItem
2026-04-088-KEntry into a material agreement, Financial statements and exhibitsfiling
2026-03-278-KEntry into a material agreement, Completion of an acquisition, Financial statements and exhibitsfiling
2026-03-138-KEntry into a material agreement, Regulation FD disclosure, Other material eventfiling
2025-12-108-KEntry into a material agreement, Completion of an acquisition, Item 3.02filing
2025-12-038-KEntry into a material agreement, Completion of an acquisition, Item 3.02filing
2025-09-088-KEntry into a material agreement, Item 2.03, Regulation FD disclosurefiling
2025-08-258-KEntry into a material agreement, Financial statements and exhibitsfiling
2025-08-148-KEntry into a material agreement, Item 3.02, Financial statements and exhibitsfiling
2025-08-118-KEntry into a material agreement, Item 2.03, Item 3.02filing
2025-08-058-KEntry into a material agreement, Item 3.02, Director or officer departurefiling
2025-07-308-KEntry into a material agreement, Item 3.02, Item 5.01filing
2025-05-0810-K/Afiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKO HEALTH, INC.12compare →
FIBROGEN INC12compare →
PALATIN TECHNOLOGIES INC12compare →
Oncotelic Therapeutics, Inc.12compare →
NEKTAR THERAPEUTICS12compare →
ALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition